RichardJCoteMDFRCPath, FCAP

Pathology • Saint Louis, MO

Genitourinary Pathology, Anatomic Pathology, Clinical Pathology, Surgical Pathology

Professor and Chair, Department of Pathology and Immunology at Washington Univeristy School of Medicine in St. Louis

Join to view full profile

Dr. Cote is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Cote's full profile

Already have an account?

Office
1 Barnes Jewish Hospital Plz
# Div
Saint Louis, MO 63110
Phone+1 314-362-5641

Fax+1 314-362-0369

Summary

Dr. Richard Cote is the Chair of the Department of Pathology and Immunology at Washington University School of Medicine in St. Louis and is the Chief of the Pathology Service at Barnes-Jewish Hospital. Previously he was Chair of Pathology at University of Miami, and prior to that was a member of the faculty at the University of Southern California Keck School of medicine. He received his medical degree from University of Chicago Division of the Biological Sciences The Pritzker School of Medicine and has been in practice 37 years. He specializes in genitourinary pathology, anatomic pathology, clinical pathology, and surgical pathology and is experienced in breast cancer, genitourinary cancer, prostatectomy, biopsies, and adenocarcinoma.

Education & Training

New York University School of MedicinePost-Doctoral Fellowship, 1989 - 1990
Chief Fellow - Memorial Sloan-Kettering Cancer CenterPathology, 1988 - 1990
Memorial Sloan Kettering Cancer CenterFellowship, Surgical Pathology, 1987 - 1988
New York Presbyterian Hospital (Cornell Campus)Residency, Pathology-Anatomic and Clinical, 1985 - 1987
Memorial Sloan Kettering Cancer CenterPost-Doctoral Fellowship, 1981 - 1983
University of Michigan Health SystemInternship, Surgical Internship, 1980 - 1981
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1980

Certifications & Licensure

IL State Medical License 2020 - 2026
FL State Medical License 2008 - 2025
MO State Medical License 2019 - 2025
CA State Medical License 1990 - 2022
American Board of Pathology Anatomic Pathology

Awards, Honors, & Recognition

Saint Louis Magazine Top Doctor Saint Louis Magazine, 2020-2022
America's Top Doctors for Cancer Castle Connolly, 2005-2022
America's Top Doctors Castle Connolly, 2002-2022
National Academy of Inventors, elected member National Academy of Inventors, 2021
Top Doctors:South Florida Castle Connolly, 2009-2019
Bio-Medical Health Care Heroes Award Miami Chamber of Commerce, 2015
Association of American Physicians, elected member Association of American Physicians, 2010
Super Doctor SuperDoctors.com
Whos Who in Medicine and Healthcare Marquis Whos Who
Join now to see all

Clinical Trials

4B951, Combination Chemotherapy in Treating Patients With Bladder Cancer Start of enrollment: 1997 Aug 01
Terminated
Phase 3
Trial of Prostate Cancer Patients Undergoing Active Surveillance With or Without MRI-Guided Management Start of enrollment: 2012 Aug 01
Withdrawn
MRI Based Active Selection for Treatment Trial Start of enrollment: 2014 Nov 12
Active, not recruiting
Not Applicable

Publications & Presentations

PubMed

7 citations
Human-derived osteoblast-like cells and pericyte-like cells induce distinct metastatic phenotypes in primary breast cancer cells.
Vera Mayo, Annie C. Bowles, Laura Wubker, Ismael Ortiz, Albert M Cordoves
Experimental Biology and Medicine. 2021-04-01
14 citations
Immunohistochemical markers of prognostic value in surgical pathology.
Clive R. Taylor, Richard J. Cote
Histology and Histopathology. 1997-10-01
41 citations
Incidence of Occult Lymph Node Metastases in Pathological Stage C (pT3NO) Prostate Cancer
John Freeman, David Esrig, Gary D. Grossfeld, John P. Stein, Chen Su-Chiu
The Journal of Urology. 1995-08-01

Other

Urine biomarkers for the detection of urothelial (transitional cell) carcinoma of the bladder
Cote RJ, Mitra AP, Penson DF, Birkhahn M
http://www.uptodate.com/contents/urine-biomarkers-for-the-detection-of-urothelial-transitional-cell-
UpToDate, Wolters Kluwer Health - 2012-08-02

Press Mentions

Huang Named Head of Pathology & ImmunologySeptember 12th, 2024
Medicare Approves Genetic Test for Solid TumorsFebruary 22nd, 2024
Obituary: Emil Raphael Unanue, Renowned Immunologist, 88December 24th, 2022
Join now to see all

Grant Support

A comprehensive liquid biopsy platform for detection and prognostication in early stage breast cancerNIH/National Cancer Institute2018–2023
Miami Clinical and Translational Science InstituteNIH2012–2017
Culturing Viably Captured Circulating Tumor Cells Using Conditional ReprogrammingNIH/National Cancer Institute2013–2015
Development of Laser Mediated Nanodroplet Real-Time PCR on Circulating Tumor Cells (CTC) Captured by Microfilter PlatformDOD2012–2014
Integrated Biomarker Profiling for Individualized Prostate Cancer TherapyBankhead-Coley Cancer Research Program2010–2013
Integrated Device for Circulating Tumor Cell Capture, Characterization and Lens- Free MicroscopyDepartment of Defense/Breast Cancer Research Program Synergistic Idea Award2009–2012
Molecular Analysis of Neoadjuvant Platinum in Triple Negative Breast CancerNIH/National Cancer Institute2009–2012
Integrated Microdevice To Capture And Detect Circulating Tumor CellsNational Cancer Institute2010–2011
Validation of MAP2K6 as a Therapeutic Target for Metastatic Bladder CancerNIH/National Cancer Institute2009–2010
Molecular Analysis Of Neoadjuvant Platinum In Triple Negative Breast CancerNational Cancer Institute2009–2010
Circulating Tumor Cell Capture &Analysis In A Multi-Center Prostate Cancer TrialNational Cancer Institute2009–2010
Multiplexed Nanosensing For DNA And ProteinsNational Institute Of Biomedical Imaging And Bioengineering2008–2009
Multiplexed Nanosensing For DNA And ProteinsNational Institute Of Biomedical Imaging And Bioengineering2007–2008
Integrated Microdevice To Capture And Detect Circulating Tumor CellsNational Cancer Institute2006–2007
Mcav In Organ-Confined Bladder CA Based On P53 StatusNational Cancer Institute2003–2006
Bone Marrow &Sentinel Node Micrometastases In Breast CANational Cancer Institute2000–2004
Detection Of Occult Metastases In Lung Cancer PatientsNational Cancer Institute2000–2003
Molecular /Cellular Pathways Of Bladder Cancer ProgressionNational Cancer Institute2002
Core--PathologyNational Cancer Institute2002
Pilot--Genitourinary CancerNational Cancer Institute2001–2002
MVAC In Organ-Confined Bladder Cancer Based P53 StatusNational Cancer Institute2001–2002
MVAC In Bladder Cancer Based On P53 StatusNational Cancer Institute1999
Molecular/Cellular Pathways Of Bladder Ca++ ProgressionNational Cancer Institute1996–1999
MVAC In Organ-Confined Bladder Cancer Based On P53 StatuNational Cancer Institute1998
Generation And Analysis Of Human Monoclonal AntibodiesNational Cancer Institute1985